Figures & data
Table 1. Primer sequences of mRNA and lncRNA.
Figure 1. Characterisation of the HaCaT-derived small extracellular vesicles (sEV). (A) The ultrastructure of the two types of sEV was observed using transmission electron microscopy (TEM). Scale bar: 200 nm. Red arrow indicates the representative morphology of the sEV. (B) The size distribution of the sEV was measured using NanoSight analysis. (C) sEV-related markers and negative markers were detected using western blotting. (D) Laser scanning confocal microscopy was used to detect the presence of HaCaT-derived sEV (pre-labelled with PKH26) in fibroblasts.
![Figure 1. Characterisation of the HaCaT-derived small extracellular vesicles (sEV). (A) The ultrastructure of the two types of sEV was observed using transmission electron microscopy (TEM). Scale bar: 200 nm. Red arrow indicates the representative morphology of the sEV. (B) The size distribution of the sEV was measured using NanoSight analysis. (C) sEV-related markers and negative markers were detected using western blotting. (D) Laser scanning confocal microscopy was used to detect the presence of HaCaT-derived sEV (pre-labelled with PKH26) in fibroblasts.](/cms/asset/165d91ef-ce7d-4833-a205-09ed6f62e38c/iarp_a_2358020_f0001_c.jpg)
Figure 2. HaCaT-HG-sEV inhibits the biological function of fibroblasts. (A–D) The migration ability of fibroblasts treated with PBS, HM-sEV, or HG-sEV was examined using scratch and transwell assays. (E, F) The protein expression levels of collagen types I and III in fibroblasts treated with PBS, HM-sEV, or HG-sEV were examined using western blotting. (G) The mRNA expression of collagen I and III was validated using quantitative real-time polymerase chain reaction (qRT-PCR). (H) The levels of collagen I and III were examined using enzyme-linked immunosorbent assay (ELISA) kit. (I–K) Cell proliferation level was measured using CCK-8 and Edu staining assay. (L–O) Cell apoptosis and cell cycle were analysed using flow cytometry. *p < 0.05, **p < 0.01, ***p < 0.001.
![Figure 2. HaCaT-HG-sEV inhibits the biological function of fibroblasts. (A–D) The migration ability of fibroblasts treated with PBS, HM-sEV, or HG-sEV was examined using scratch and transwell assays. (E, F) The protein expression levels of collagen types I and III in fibroblasts treated with PBS, HM-sEV, or HG-sEV were examined using western blotting. (G) The mRNA expression of collagen I and III was validated using quantitative real-time polymerase chain reaction (qRT-PCR). (H) The levels of collagen I and III were examined using enzyme-linked immunosorbent assay (ELISA) kit. (I–K) Cell proliferation level was measured using CCK-8 and Edu staining assay. (L–O) Cell apoptosis and cell cycle were analysed using flow cytometry. *p < 0.05, **p < 0.01, ***p < 0.001.](/cms/asset/5552a0ef-30aa-4885-a2f7-98217606f206/iarp_a_2358020_f0002_c.jpg)
Figure 3. sEV-packaged LINC01435 suppresses biological function in human skin fibroblasts. (A–C) qRT-PCR was used to detect the differential expression of LINC01435 in HaCaT cells, HaCaT-sEV, and fibroblasts stimulated using high glucose. (D) qRT-PCR was used to confirm successful transfection of plasmid carrying LINC01435 into fibroblasts. (E–H) The migration ability of LINC01435-overexpressing fibroblasts was examined using scratch and transwell assays. (I, J) The protein expression of collagen I and III in LINC01435-overexpressing fibroblasts was examined using western blotting. (K) The levels of collagen I and III were examined using ELISA kits. (L) mRNA expression of collagen I and III was validated using qRT-PCR. (M) Cell proliferation level was measured using a CCK-8 assay. (N, O) Cell apoptosis was analysed using flow cytometry. *p < 0.05, **p < 0.01, ***p < 0.001.
![Figure 3. sEV-packaged LINC01435 suppresses biological function in human skin fibroblasts. (A–C) qRT-PCR was used to detect the differential expression of LINC01435 in HaCaT cells, HaCaT-sEV, and fibroblasts stimulated using high glucose. (D) qRT-PCR was used to confirm successful transfection of plasmid carrying LINC01435 into fibroblasts. (E–H) The migration ability of LINC01435-overexpressing fibroblasts was examined using scratch and transwell assays. (I, J) The protein expression of collagen I and III in LINC01435-overexpressing fibroblasts was examined using western blotting. (K) The levels of collagen I and III were examined using ELISA kits. (L) mRNA expression of collagen I and III was validated using qRT-PCR. (M) Cell proliferation level was measured using a CCK-8 assay. (N, O) Cell apoptosis was analysed using flow cytometry. *p < 0.05, **p < 0.01, ***p < 0.001.](/cms/asset/9e77adb6-3890-4db3-a488-3c7438ffd18c/iarp_a_2358020_f0003_c.jpg)
Figure 4. LINC01435 suppresses the biological function of fibroblasts by triggering autophagy. (A) TEM analysis of fibroblasts treated with PBS, HM-sEV, or HG-sEV. Arrow heads indicate autophagosomes. (B, C) The expression of the autophagy-related proteins LC3 and Beclin-1 in fibroblasts treated with PBS, HM-sEV, or HG-sEV was examined using western blotting. (D) TEM analysis of LINC01435-overexpressing fibroblasts. Arrow heads indicate autophagosomes. (E, F) The expression of the autophagy-related proteins LC3 and Beclin-1 in LINC01435-overexpressing fibroblasts was detected using western blotting. (G) The expression of the autophagy-related proteins LC3 and Beclin-1 in LINC01435-overexpressing fibroblasts was detected using immunofluorescence assay. (H, I) Autophagy flux was observed in LINC01435-overexpressing fibroblasts infected with MRFP-GFP-LC3 using laser confocal microscopy, and semi-quantitative analysis of autophagosomes and autolysosomes (including the yellow and red fluorescent spots in merged images) was conducted. (J–M) Treatment with 3-MA restored collagen protein expression and the migration ability in LINC01435-overexpressing fibroblasts. *p < 0.05, **p < 0.01, ***p < 0.001.
![Figure 4. LINC01435 suppresses the biological function of fibroblasts by triggering autophagy. (A) TEM analysis of fibroblasts treated with PBS, HM-sEV, or HG-sEV. Arrow heads indicate autophagosomes. (B, C) The expression of the autophagy-related proteins LC3 and Beclin-1 in fibroblasts treated with PBS, HM-sEV, or HG-sEV was examined using western blotting. (D) TEM analysis of LINC01435-overexpressing fibroblasts. Arrow heads indicate autophagosomes. (E, F) The expression of the autophagy-related proteins LC3 and Beclin-1 in LINC01435-overexpressing fibroblasts was detected using western blotting. (G) The expression of the autophagy-related proteins LC3 and Beclin-1 in LINC01435-overexpressing fibroblasts was detected using immunofluorescence assay. (H, I) Autophagy flux was observed in LINC01435-overexpressing fibroblasts infected with MRFP-GFP-LC3 using laser confocal microscopy, and semi-quantitative analysis of autophagosomes and autolysosomes (including the yellow and red fluorescent spots in merged images) was conducted. (J–M) Treatment with 3-MA restored collagen protein expression and the migration ability in LINC01435-overexpressing fibroblasts. *p < 0.05, **p < 0.01, ***p < 0.001.](/cms/asset/8417f566-3d08-40cd-aade-9c8bd4de90e6/iarp_a_2358020_f0004_c.jpg)
Figure 5. HG-sEV suppress cutaneous wound healing in db/db mice in vivo. (A, B) Representative images of cutaneous wounds treated with PBS, HM-sEV, or HG-sEV at 0, 6, and 11 days post-wounding. (C) HE staining of wound sections after different treatments at 11 days post-wounding. The double-headed arrows represent the edge of the scar. (D) The extent of scar widths of three groups was measured at 11 days post-wounding. (E) Transmitted light images of Masson’s staining and Sirius red staining of three groups to evaluate collagen maturity. (F, G) Immunohistochemical staining to determine collagen I and III, Beclin-1, and LC3B protein expression in skin tissues and related quantitative analyses were performed according to the IRS. *p < 0.05, **p < 0.01, ***p < 0.001.
![Figure 5. HG-sEV suppress cutaneous wound healing in db/db mice in vivo. (A, B) Representative images of cutaneous wounds treated with PBS, HM-sEV, or HG-sEV at 0, 6, and 11 days post-wounding. (C) HE staining of wound sections after different treatments at 11 days post-wounding. The double-headed arrows represent the edge of the scar. (D) The extent of scar widths of three groups was measured at 11 days post-wounding. (E) Transmitted light images of Masson’s staining and Sirius red staining of three groups to evaluate collagen maturity. (F, G) Immunohistochemical staining to determine collagen I and III, Beclin-1, and LC3B protein expression in skin tissues and related quantitative analyses were performed according to the IRS. *p < 0.05, **p < 0.01, ***p < 0.001.](/cms/asset/5de6a1b0-f299-47c7-82ec-9eecb0ab230f/iarp_a_2358020_f0005_c.jpg)
Figure 6. Schematic of the potential mechanism by which HaCaT-sEV regulates the biological functions of fibroblasts in diabetic wound healing. In this study, LINC01435-containing HG-sEV were transferred to skin fibroblasts, triggering autophagy and decreasing collagen synthesis in fibroblasts, thereby delaying wound healing in vivo.
![Figure 6. Schematic of the potential mechanism by which HaCaT-sEV regulates the biological functions of fibroblasts in diabetic wound healing. In this study, LINC01435-containing HG-sEV were transferred to skin fibroblasts, triggering autophagy and decreasing collagen synthesis in fibroblasts, thereby delaying wound healing in vivo.](/cms/asset/17d1590a-c603-4546-b77f-89b0bcc87b2c/iarp_a_2358020_f0006_c.jpg)
Data availability statement
The data that support the findings of this study are available on request from the corresponding author (LY).